Emyria’s Dr Michael Winlo brings investors up to speed on a phase one trial for the company’s ultra-pure cannabidiol (CBD) capsules. The final patients in a 12-person cohort will be dosed with the EMD-RX5 formulation in Adelaide today. Dr Winlo believes EMD-RX5 has the potential to address multiple clinical indications as a registered medicine where…
Canntab Therapeutics CFO Richard Goldstein joined Steve Darling from Proactive to share news the company has completed its first shipment of 5 mg THC tablets to the Ontario Cannabis Store. Goldstein talks about that milestone and also that Canntab completed its second shipment of both THC and CBD tablets to Australia. Goldstein also shared with…
Canntab Therapeutics Ltd CFO Richard Goldstein tells Proactive that it has entered into an affiliate agreement with OnPharm-United, a 600-plus network of independent pharmacy owners throughout the Province of Ontario. The company said all member pharmacies will have access to educational information on medical cannabis, Canntab’s exclusive hard tablet medical products including cannabidiol (CBD) and…
Nextleaf Solutions CEO Paul Pedersen joined Steve Darling from Proactive to share news the company has hit another key milestone to drive growth. The company has completed its initial shipment of Glacial Gold vapes and distilled oils to the Ontario Cannabis Store. Glacial Gold is expected to be at retail in early May. Pedersen also…
Emyria Ltd’s Michael Winlo tells Andrew Scott about its new ultra pure cannabidiol (CBD) capsule – RX7 – which offers high bio-availability. This opens up the opportunity for the company to pursue prescription registration for indications that require a very high dose of CBD, such as anxiety, epilepsy, fibromyalgia and pain conditions. A Phase 1…